Press Release | Frontier Medicines

Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting

August 25, 2025/in 2022, Press Release/by eallison

March 9, 2022

Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer

August 25, 2025/in 2022, Press Release/by eallison

March 8, 2022

Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board

August 25, 2025/in 2022, Press Release/by eallison

February 8, 2022

Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie

August 25, 2025/in 2022, Press Release/by eallison

January 10, 2022

Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference

August 25, 2025/in 2022, Press Release/by eallison

January 5, 2022

Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

August 25, 2025/in 2021, Press Release/by eallison

December 9, 2021

Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer

August 25, 2025/in 2021, Press Release/by eallison

November 17, 2021

Frontier Medicines to Present at Two Upcoming Investor Conferences in November

August 25, 2025/in 2021, Press Release/by eallison

November 10, 2021

Frontier Medicines to Present at the Cantor Global Healthcare Conference

August 25, 2025/in 2021, Press Release/by eallison

September 23, 2021

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

August 25, 2025/in 2021, Press Release/by eallison

July 19, 2021

Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting

Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer

Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board

Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie

Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference

Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer

Frontier Medicines to Present at Two Upcoming Investor Conferences in November

Frontier Medicines to Present at the Cantor Global Healthcare Conference

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

Our Locations

South San Francisco Office

Boston Office